icon
-
Press ReleaseNovartis receives approval for first malaria medicine for newborn babies and young infants
-
Press ReleaseNovartis and Medicines for Malaria Venture announce decision to move to Phase 3 study for novel ganaplacide/lumefantrine-SDF combination in adults and children with malaria
-
Story
Sickle cell screening urged for newborns in Africa -
Story
How Emily’s act of bravery inspired a wave of continued innovation -
Press ReleaseNovartis to initiate SMART Phase 3b global study of Zolgensma in children up to 21 kg, building on real-world experience
-
Press ReleaseNovartis Cosentyx® receives EU approval for first-line systemic treatment in pediatric psoriasis
-
Story
Visionary: Silke Mader has a vision for the care of premature infants and their parents -
Story
One boy’s quest to battle cancer -
Story
Fighting respiratory disease at the source -
Story
The specter of malaria that resists treatment -
Story
Women in Science: Hannah Mosca -
Story
Fighting pneumonia, the biggest killer of young children